Bill Search

  • Introduced
    Nov 03, 2021
  • Passed Senate
    May 24, 2022
  • Passed Assembly
  • Signed into Law
S 7499
New York Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs
Last Action See all actions
Assembly • May 24, 2022: REFERRED TO HEALTH
Latest Bill Text See all bill texts

Official Summary/Bill Text

Comments on S 7499

Tweets

Whip Lists

Sponsors
Actions
  • May 24, 2022 | Assembly
    • REFERRED TO HEALTH
  • May 24, 2022 | Senate
    • PASSED SENATE
    • DELIVERED TO ASSEMBLY
  • May 17, 2022 | Senate
    • AMENDED 7499B
    • ADVANCED TO THIRD READING
  • May 16, 2022 | Senate
    • 2ND REPORT CAL.
  • May 11, 2022 | Senate
    • 1ST REPORT CAL.1338
  • May 05, 2022 | Senate
    • AMEND (T) AND RECOMMIT TO HEALTH
    • PRINT NUMBER 7499A
  • Jan 05, 2022 | Senate
    • REFERRED TO HEALTH
  • Nov 03, 2021 | Senate
    • REFERRED TO RULES
Documents
Looks like we don't have any documents available at this moment.